McKesson Corporation $MCK Holdings Boosted by Fisher Asset Management LLC

Fisher Asset Management LLC raised its stake in shares of McKesson Corporation (NYSE:MCK – Free Report) by 47.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,372 shares of the company’s stock after acquiring an additional 1,090 shares during the period. Fisher Asset Management LLC’s holdings in McKesson were worth $2,880,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MCK. Rosenberg Matthew Hamilton lifted its position in McKesson by 2.8% during the 3rd quarter. Rosenberg Matthew Hamilton now owns 406 shares of the company’s stock worth $347,000 after acquiring an additional 11 shares during the period. Avail Investment Partners LLC increased its holdings in shares of McKesson by 1.7% in the third quarter. Avail Investment Partners LLC now owns 662 shares of the company’s stock valued at $566,000 after purchasing an additional 11 shares during the period. Commonwealth Financial Services LLC raised its stake in shares of McKesson by 3.8% during the third quarter. Commonwealth Financial Services LLC now owns 304 shares of the company’s stock worth $260,000 after purchasing an additional 11 shares during the last quarter. WealthPLAN Partners LLC raised its stake in shares of McKesson by 0.4% during the third quarter. WealthPLAN Partners LLC now owns 3,190 shares of the company’s stock worth $2,724,000 after purchasing an additional 12 shares during the last quarter. Finally, Arista Wealth Management LLC raised its stake in shares of McKesson by 1.0% during the second quarter. Arista Wealth Management LLC now owns 1,446 shares of the company’s stock worth $1,093,000 after purchasing an additional 14 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Trading Up 0.3%

NYSE MCK opened at $1,105.77 on Tuesday. The stock has a market capitalization of $127.67 billion, a price-to-earnings ratio of 28.43, a PEG ratio of 1.82 and a beta of 0.27. The business’s 50 day moving average is $959.41 and its two-hundred day moving average is $875.93. McKesson Corporation has a 12-month low of $723.68 and a 12-month high of $1,121.50.

McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating the consensus estimate of $10.72 by $0.96. McKesson had a negative return on equity of 202.94% and a net margin of 1.12%. The business had revenue of $110.96 billion during the quarter, compared to analysts’ expectations of $109.90 billion. During the same period last year, the firm earned $9.86 EPS. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. Equities analysts forecast that McKesson Corporation will post 46.16 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be given a $0.94 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio is presently 9.67%.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Francisco Fraga sold 800 shares of the business’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the sale, the executive vice president directly owned 5,423 shares in the company, valued at approximately $5,400,223.40. The trade was a 12.86% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the company’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $891.45, for a total transaction of $98,950.95. Following the transaction, the chief accounting officer directly owned 521 shares in the company, valued at approximately $464,445.45. This trade represents a 17.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161 shares of company stock valued at $2,242,515 in the last quarter. 0.06% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Citigroup increased their price target on McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a report on Friday, July 24th. Barclays boosted their price objective on shares of McKesson from $925.00 to $1,000.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Weiss Ratings upgraded shares of McKesson from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday, November 9th. Argus upped their price objective on shares of McKesson from $850.00 to $970.00 and gave the stock a “buy” rating in a research report on Thursday, September 3rd. Finally, Leerink Partners raised their target price on shares of McKesson from $1,070.00 to $1,200.00 and gave the stock an “outperform” rating in a research note on Thursday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $1,040.29.

Check Out Our Latest Report on McKesson

McKesson Profile

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Featured Articles

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.